ABC zaawansowanego raka prostaty - oporność na kastrację, leczenie skojarzone, mutacje BRCA1/2

Recent years have brought many changes in access to modern treatment for prostate cancer patients, but most of them have concerned the first stage of the disease. First, because, as we know, prostate cancer has many facets. In many men, this cancer can be successfully treated for a long time without causing many difficulties in the patient's life. Unfortunately, some patients will be diagnosed a second time. This means their cancer will no longer respond to previous treatment and will become resistant to it. The disease will enter a new stage, a new chapter. Difficult and incurable. What then? Modern combination therapies may offer hope for this group of patients. By combining modern hormone therapy with PARP inhibitors, patients, regardless of their molecular status, can gain a chance at a longer life. Anna Kupiecka, president of the OnkoCafe – Razemlepszy Foundation, and Paweł Potocki, MD, PhD, a clinical oncologist at the Department of Oncology at the Jagiellonian University Medical College, spoke about living with advanced castration-resistant prostate cancer. 🔔 SUBSCRIBE TO OUR CHANNEL https://www.youtube.com/@Pacjenci/?su... 🔔 health, medical advice, healthy diet You can find us on: ➡️ https://pacjenci.pl ➡️ on Facebook:   / pacjenci   ➡️ on TikTok:   / pacjenci   PACJENCI.PL - daily news from the world of health and medicine. We write about health, sports, treatment, and nutrition. Live a healthy life. #PACJENCI